APOL1 research is driving precision nephrology, but prediction gaps and equity challenges still limit clinical impact.
John Cijan He, MD, PhD
Advertisement
John Cijan He, MD, PhD, is a Professor of Medicine and Pharmacological Sciences and Chief of the Division of Nephrology at the Icahn School of Medicine at Mount Sinai.
Articles by John Cijan He, MD, PhD
An expert shares his perspective on emerging targets and precision strategies for podocyte injury in glomerular disease.
Advertisement